William H. Westra
Papers
4
Total Citations
88
H-Index
3
About
William H. Westra is a leading pathologist whose research has fundamentally reshaped the understanding and management of human papillomavirus-related oropharyngeal squamous cell carcinoma (HPV+ OPSCC). His major contributions center on de-escalating treatment to reduce toxicity without compromising survival, and precisely defining the risk of contralateral neck disease in early-stage patients. As a key investigator in the landmark Sinai Robotic Surgery (SIRS) Trial (62 citations), Westra demonstrated that upfront transoral robotic surgery followed by reduced-dose adjuvant therapy can achieve excellent outcomes while minimizing harmful side effects. His work on contralateral nodal spread—including studies with 14 and 2 citations—has provided critical pathologic evidence to guide surgeons in safely limiting the extent of neck dissection, thereby reducing morbidity. Westra’s research also characterizes long-term outcomes after treatment failure, offering vital insights for managing recurrent disease. Through these contributions, he has helped establish a new, more patient-centered standard of care for HPV+ OPSCC, balancing high survival rates with improved quality of life. His work remains essential reading for clinicians and researchers seeking to optimize therapy in the HPV era.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4